VHT vs XLV

Key Takeaways

• Vanguard Health Care ETF (VHT) offers broader exposure across large-, mid-, and small-cap U.S. health care stocks through the MSCI US Investable Market Health Care 25/50 Index, while Health Care Select Sector SPDR Fund (XLV) concentrates on large-cap companies within the S&P 500 via the Health Care Select Sector Index.
• XLV maintains a lower expense ratio of 0.08% compared to VHT’s 0.09%, providing a modest cost advantage for long-term holders.
• VHT holds approximately 415–424 securities for greater diversification, whereas XLV typically contains around 62 holdings, resulting in higher concentration in top positions.
• Both ETFs employ passive, market-capitalization-weighted strategies focused exclusively on the health care sector, with no active management, leverage, or thematic overlays.
• Top holdings in both funds overlap significantly in large pharmaceutical and biotechnology names, though VHT’s inclusion of smaller firms introduces modestly different risk and return drivers over market cycles.
• Liquidity remains robust for both, supported by high trading volumes and tight bid-ask spreads typical of established sector ETFs.

Introduction

Investors seeking targeted exposure to the U.S. health care sector often evaluate Vanguard Health Care ETF (VHT) and Health Care Select Sector SPDR Fund (XLV) as core options. These two ETFs compete directly within the same sector but deliver distinct profiles: VHT provides comprehensive market-cap breadth, while XLV emphasizes large-cap stability. The comparison helps clarify trade-offs in diversification, cost, and concentration that matter for portfolio construction amid ongoing sector rotation and earnings cycles.

Vanguard Health Care ETF (VHT) Overview

Vanguard Health Care ETF (VHT) tracks the MSCI US Investable Market Health Care 25/50 Index, a market-capitalization-weighted benchmark covering large-, mid-, and small-cap U.S. health care companies classified under the Global Industry Classification Standard. The fund holds approximately 415–424 securities and employs a replication or sampling approach to minimize tracking error. Its expense ratio stands at 0.09%. Top holdings typically account for roughly 52% of assets, with sector allocations spanning pharmaceuticals, biotechnology, health care equipment, providers, and related services. As a passive index ETF, VHT rebalances periodically to maintain alignment with the index weights.

Health Care Select Sector SPDR Fund (XLV) Overview

Health Care Select Sector SPDR Fund (XLV) seeks to replicate the Health Care Select Sector Index, which comprises health care companies from the S&P 500. The ETF typically holds about 62 securities and uses a market-capitalization-weighted methodology with full replication. Its expense ratio is 0.08%. Concentration is higher, with the top 10 holdings representing approximately 61% of assets, focused on large-cap names in pharmaceuticals, biotechnology, equipment, and services. XLV is a passive sector ETF that rebalances in line with index changes and S&P 500 constituent adjustments.

Industry and Thematic Backdrop

The health care sector continues to navigate demographic tailwinds from aging populations, innovation in pharmaceuticals and biotechnology, and evolving regulatory frameworks around drug pricing and approvals. Macroeconomic factors such as interest rate expectations and broader equity market sentiment influence capital flows into defensive growth areas. Potential risks include policy changes, patent expirations, and competition within key sub-industries. Both ETFs remain positioned to capture sector-wide developments without exposure to non-health care segments.

Performance and Positioning Comparison

Over recent market cycles, the broader diversification in Vanguard Health Care ETF (VHT) has contributed to modestly different volatility profiles compared with the more concentrated Health Care Select Sector SPDR Fund (XLV). XLV’s emphasis on large-cap leaders has supported relative stability during periods of sector rotation favoring established pharmaceutical and biotechnology firms. VHT’s inclusion of mid- and small-cap holdings can enhance participation in growth phases driven by emerging companies, though it may amplify fluctuations in certain environments. Both funds exhibit sensitivity to earnings reports from top holdings and shifts in interest rate outlooks that affect valuation multiples across the sector.

AI Screener

Tickeron’s AI Screener is an AI-powered stock and ETF discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener helps identify trade ideas, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening. Visit the AI Screener to explore current opportunities.

Tickeron AI Verdict

Based on observable structural factors, Tickeron’s AI would currently assign a modest probabilistic preference to Health Care Select Sector SPDR Fund (XLV) due to its lower expense ratio, high liquidity, and concentrated exposure to large-cap sector leaders that have demonstrated consistent trend participation in recent cycles. Vanguard Health Care ETF (VHT) offers compelling diversification benefits for investors prioritizing broader market-cap coverage, though the cost and concentration profile of XLV align more closely with efficiency and momentum considerations under current conditions.

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.